Damora Therapeutics, Inc. - Ordinary Shares (DMRA)

Last Price27.85

Change-0.33 (-1.19%)

NASDAQ· Last Trade: Sep 3rd, 1:14 PM EDT

This clinical-stage biotech develops small molecule therapies for cancer and fibrotic diseases, focusing on galectin-3 and LOXL2 inhibitors.

Via The Motley Fool · May 30, 2026